Biogen Interest Expense from 2010 to 2026

IDP Stock  EUR 165.80  4.45  2.76%   
Biogen's Interest Expense is increasing over the last several years with slightly volatile swings. Interest Expense is predicted to flatten to about 171.9 M. Interest Expense is the cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit. View All Fundamentals
 
Interest Expense  
First Reported
2017-03-31
Previous Quarter
67.4 M
Current Value
67.5 M
Quarterly Volatility
M
 
Covid
 
Interest Hikes
Check Biogen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biogen's main balance sheet or income statement drivers, such as Interest Expense of 171.9 M, Selling General Administrative of 2.5 B or Total Revenue of 9.1 B, as well as many indicators such as . Biogen financial statements analysis is a perfect complement when working with Biogen Valuation or Volatility modules.
  
This module can also supplement various Biogen Technical models . Check out the analysis of Biogen Correlation against competitors.
The Interest Expense trend for Biogen Inc offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Biogen is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Biogen's Interest Expense Growth Pattern

Below is the plot of the Interest Expense of Biogen Inc over the last few years. It is the cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit. Biogen's Interest Expense historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Biogen's overall financial position and show how it may be relating to other accounts over time.
Interest Expense10 Years Trend
Slightly volatile
   Interest Expense   
       Timeline  

Biogen Interest Expense Regression Statistics

Arithmetic Mean120,430,098
Geometric Mean0.00
Coefficient Of Variation99.16
Mean Deviation113,345,975
Median171,911,666
Standard Deviation119,413,022
Sample Variance14259.5T
Range267.5M
R-Value0.87
Mean Square Error3780.1T
R-Squared0.75
Slope20,499,248
Total Sum of Squares228151.5T

Biogen Interest Expense History

2026171.9 M
2025267.5 M
2024250.3 M
2023246.9 M
2022246.6 M
2021253.6 M
2020222.5 M

About Biogen Financial Statements

Biogen stakeholders use historical fundamental indicators, such as Biogen's Interest Expense, to determine how well the company is positioned to perform in the future. Although Biogen investors may analyze each financial statement separately, they are all interrelated. For example, changes in Biogen's assets and liabilities are reflected in the revenues and expenses on Biogen's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Biogen Inc. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Interest Expense267.5 M171.9 M

Currently Active Assets on Macroaxis

When determining whether Biogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biogen Inc Stock:
Check out the analysis of Biogen Correlation against competitors.
You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Please note, there is a significant difference between Biogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Biogen's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.